Laxman Pharma Exports

Akynzeo capsule contains the active ingredients netupitant and palonosetron. It is an antiemetic drug belonging to the class of 5-HT3  receptor antagonists. It is used to prevent and treat nausea, vomiting, or sickness caused by cancer treatments such as chemotherapy, radiotherapy, or after surgery. Nausea is characterised by stomach pain and the urge to vomit.

The common side effects that are likely to occur with this medicine are hives, swollen face, breathing trouble, and chest pain. Inform your healthcare provider if these side effects concern you or persist for longer than usual. It is given right away or later with anticancer medicines. It is usually given up to 24 hours while recovering from anesthesia after surgery. 

Talk to your physician if you have a history of repeated constipation, blockage in the bowel, heart problems, or imbalance of certain minerals in your blood (such as magnesium and potassium). This medicine should not be used if you are allergic to this drug. Tell your physician about all the medications you have been taking recently, including herbal medicines and supplements, before taking the Akynzeo capsule.

Apotinib 400mg tablet contains the active substance imatinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. This tablet is used in treating adults and children with chronic myeloid leukemia (CML- it is a form of leukemia in which certain abnormal white blood cells start growing out of control). It is also indicated to treat Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL). It is also used to treat certain types of gastrointestinal stromal tumors (GIST, a type of tumor that grows in the walls of the digestive passages and may spread to other parts of the body). 

Apotinib 400mg tablet is also used to treat myelodysplastic/myeloproliferative diseases (MDS/MPD); these are a group of blood diseases in which some blood cells start growing out of control. They also treat hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL); these are blood diseases in which some blood cells (eosinophils) start growing out of control. This medicine is also intended to treat dermatofibrosarcoma protuberans (DFSP), a cancer of the tissue beneath the skin in which some cells start growing abnormally. It works to inhibit the growth of these abnormal blood cells.  

Do not take Apotinib 400mg tablet if you are allergic to imatinib or any other ingredients of this medicine. Before initiating the treatment, inform your physician if you have kidney, heart, or liver problems, if you have thyroid problems, or if your thyroid gland has been removed. Notify your doctor if you ever had or have a hepatitis B infection because this medicine could cause the hepatitis B to become active again. Report any symptoms of bruising, bleeding, fever, fatigue, and confusion when taking this medicine. This medicine may cause fertility problems.

Elata Tablet contains Ulipristal Acetate, a selective progesterone receptor modulator (SPRM). It is commonly used in two main scenarios: as an emergency contraceptive to prevent pregnancy after unprotected sex or contraceptive failure, and in the treatment of uterine fibroids in women of reproductive age.

Common indications for Elata Tablet include:

• Emergency Contraception: Used within 120 hours (5 days) after unprotected intercourse or contraceptive failure to prevent pregnancy.
• Uterine Fibroids: Used in the management of moderate to severe symptoms of uterine fibroids, such as heavy menstrual bleeding, by reducing fibroid size and symptoms.

Dosage and Administration:

• For Emergency Contraception: One tablet (30 mg) should be taken orally as soon as possible within 120 hours after unprotected sex or contraceptive failure. It can be taken with or without food.
• For Uterine Fibroids: The dosage is typically 5 mg daily for up to 3 months, depending on the treatment plan established by a healthcare provider.

Important Usage Information:

• Ulipristal Acetate is more effective the sooner it is taken after unprotected intercourse.
• It should not be used as a routine contraceptive method, but only for emergencies.
• It is important to follow up with a healthcare provider if menstruation is delayed beyond a week after the expected time to rule out pregnancy.

Common side effects of Elata Tablet may include:

• Headache
• Abdominal pain
• Nausea
• Fatigue
• Dizziness

More serious side effects, though rare, can include severe allergic reactions or changes in menstrual patterns. Regular follow-up with a healthcare provider is recommended when using Ulipristal Acetate for the treatment of uterine fibroids.

Packaging:
Elata Tablets are typically packaged in blister packs containing 1 tablet for emergency contraception, or in packs containing multiple tablets for the treatment of uterine fibroids.

Elata Tablet (Ulipristal Acetate) is an effective option for emergency contraception and the management of uterine fibroids. Proper use and adherence to medical advice ensure optimal effectiveness and safety.

Pomalid contains Pomalidomide, which is an immunomodulatory agent that helps slow down the growth of cancer cells and boosts the immune system to attack cancer. It is commonly used in patients with multiple myeloma who have not responded well to other treatments.

Popular alternatives to Pomalid include Pomalyst and Pomalong

• Aromasin is used to treat breast cancer in postmenopausal women
• It is often given to women whose cancer has progressed even after surgery, radiation, or other cancer medications have been tried without success

Bdsure 22.5mg Injection contains Leuprolide, a gonadotropin-releasing hormone (GnRH) agonist.

• It works by reducing testosterone (in men) and estrogen (in women) levels.
• This helps slow down tumor growth and manage hormone-related conditions.

• Used in the treatment of prostate cancer.
• Also prescribed for conditions like endometriosis and uterine fibroids.

Bracanat 150mg Tablet contains Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor used in the treatment of various cancers, particularly those associated with BRCA gene mutations. Olaparib works by blocking the PARP enzyme, which helps repair damaged DNA in cells. By inhibiting this enzyme, Olaparib prevents cancer cells from repairing themselves, leading to their death.

Common indications for Bracanat 150mg Tablet include:

• Ovarian Cancer: Used in the maintenance treatment of adult patients with advanced ovarian cancer who have responded to first-line platinum-based chemotherapy.
• Breast Cancer: Used in the treatment of HER2-negative breast cancer with BRCA1/2 mutations.
• Pancreatic Cancer: Used in the maintenance treatment of BRCA-mutated metastatic pancreatic cancer.
• Prostate Cancer: Used in the treatment of metastatic castration-resistant prostate cancer with BRCA1/2 mutations.

Dosage and Administration:

• For Adults: The usual recommended dose is 300 mg (two 150 mg tablets) taken orally twice daily, for a total daily dose of 600 mg.
• Administration: The tablet should be swallowed whole with water, taken at approximately the same times each day, with or without food. It should not be crushed, chewed, or split.

Common side effects of Bracanat 150mg Tablet may include:

• Nausea
• Fatigue
• Anemia
• Vomiting
• Diarrhea
• Loss of appetite

Regular blood tests and monitoring are essential during treatment to manage potential side effects and adjust the dosage as needed.

Packaging:
Bracanat 150mg Tablet is typically packaged in blister packs containing 14 tablets, designed for a one-week course of treatment when taken as prescribed.

Bracanat 150mg Tablet is a significant advancement in cancer treatment, offering targeted therapy for patients with specific genetic mutations. It plays a crucial role in extending survival and improving the quality of life for patients with certain types of advanced cancers, particularly those associated with BRCA mutations. Regular monitoring and adherence to the prescribed regimen are vital to achieving the best possible outcomes.

100 mg Bendit (Bendamustine) Injection is a prescription anticancer (chemotherapy) medicine containing bendamustine, an alkylating agent used in the treatment of certain blood cancers such as chronic lymphocytic leukemia (CLL) and indolent B‑cell non‑Hodgkin’s lymphoma (NHL). It works by damaging the DNA of rapidly dividing cancer cells, slowing their growth and spread. This injection is given intravenously by a healthcare professional under strict medical supervision; common side effects include nausea, fatigue, infection risk, and blood cell count changes. Routine monitoring and physician guidance are essential during treatment.